Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Aspen Pharmacare Operating Margin 2017-2024 | APNHY

Current and historical operating margin for Aspen Pharmacare (APNHY) over the last 10 years. The current operating profit margin for Aspen Pharmacare as of December 31, 2024 is 0.00%.
  
Aspen Pharmacare Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $2.392B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.198B 7.04
Dr Reddy's Laboratories (RDY) India $11.797B 21.41
BridgeBio Pharma (BBIO) United States $9.344B 0.00
Bausch Health Cos (BHC) Canada $2.806B 2.02
Supernus Pharmaceuticals (SUPN) United States $2.393B 16.29
Amphastar Pharmaceuticals (AMPH) United States $1.377B 9.68
Taysha Gene Therapies (TSHA) United States $0.616B 0.00
Personalis (PSNL) United States $0.411B 0.00
Assembly Biosciences (ASMB) United States $0.201B 0.00
Sol-Gel Technologies (SLGL) Israel $0.051B 0.00
Evoke Pharma (EVOK) United States $0.009B 0.00
Teligent (TLGT) United States $0.000B 0.00